Pages that link to "Q73707803"

The following pages link to Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor (Q73707803):

Displaying 28 items.

• Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells (Q30811481) (← links)
• Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNgamma-secreting rat glioma cells. (Q31041466) (← links)
• Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts (Q33772479) (← links)
• Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors (Q34169782) (← links)
• Current gene therapy for stomach carcinoma (Q34512167) (← links)
• Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses (Q34667021) (← links)
• Applications of gene transfer to cellular immunotherapy (Q35027809) (← links)
• Cytokine modified tumor vaccines (Q35027823) (← links)
• The systemic treatment of advanced cutaneous melanoma (Q35735196) (← links)
• Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting (Q35816845) (← links)
• Cancer stem cell vaccination confers significant antitumor immunity (Q35873918) (← links)
• GM-CSF gene-transduced tumor vaccines (Q36166960) (← links)
• Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice (Q36714315) (← links)
• Antitumor activity of T cells generated from lymph nodes draining the SEA-expressing murine B16 melanoma and secondarily activated with dendritic cells (Q37073501) (← links)
• Gene-modified bone marrow cell therapy for prostate cancer (Q37127252) (← links)
• Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer (Q37346893) (← links)
• Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines (Q38936958) (← links)
• Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy (Q39543940) (← links)
• Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer (Q40330261) (← links)
• Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels (Q40744502) (← links)
• Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines (Q45734835) (← links)
• Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection (Q45884517) (← links)
• Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma (Q47197398) (← links)
• [Gene therapy of melanoma: review of published clinical trials]. (Q53859748) (← links)
• Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer (Q73031931) (← links)
• Cancer vaccines (Q77057632) (← links)
• Melanoma vaccines (Q78567097) (← links)
• Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings (Q80794415) (← links)